Hamilton Capital Partners (Canada)’s Gilead Sciences GILD Stock Holding History

Hamilton Capital Partners (Canada)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.89M	Buy	54,572 +8,005	+17%	+$1.05M	0.2%	95
2026 Q1	$6.49M	Sell	46,567 -1,874	-4%	-$262K	0.22%	75
2025 Q4	$5.95M	Buy	48,441 +6,500	+15%	+$790K	0.22%	87
2025 Q3	$4.66M	Sell	41,941 -3,110	-7%	-$353K	0.19%	96
2025 Q2	$4.99M	Buy	45,051 +7,704	+21%	+$820K	0.25%	81
2025 Q1	$4.18M	Sell	37,347 -6,831	-15%	-$705K	0.27%	78
2024 Q4	$4.08M	Sell	44,178 -8,105	-16%	-$730K	0.3%	64
2024 Q3	$4.38M	Buy	+52,283	New	+$3.99M	0.38%	65

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Hamilton Capital Partners (Canada)'s GILD Position: Q2 2026 in Review

Hamilton Capital Partners (Canada) increased its Gilead Sciences (GILD) stake by 17% in Q2 2026, buying an estimated $1.05M and bringing the position to 54,572 shares worth $6.89M. The position accounts for 0.2% of the portfolio, ranked #95.

Hamilton Capital Partners (Canada) first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. 2,169 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Hamilton Capital Partners (Canada) held 54,572 shares of Gilead Sciences worth $6.89M as of Q2 2026.
Hamilton Capital Partners (Canada) bought 8,005 Gilead Sciences shares in Q2 2026, an estimated $1.05M.
Gilead Sciences made up 0.2% of Hamilton Capital Partners (Canada)'s portfolio in Q2 2026, its #95 holding.
Hamilton Capital Partners (Canada) first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
2,169 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.